Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 231

1.

Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough.

Fackler WK, Ours TM, Vaezi MF, Richter JE.

Gastroenterology. 2002 Mar;122(3):625-32.

PMID:
11874994
2.

Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure.

Ours TM, Fackler WK, Richter JE, Vaezi MF.

Am J Gastroenterol. 2003 Mar;98(3):545-50.

PMID:
12650785
3.

Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.

Mainie I, Tutuian R, Castell DO.

J Clin Gastroenterol. 2008 Jul;42(6):676-9. doi: 10.1097/MCG.0b013e31814a4e5c.

PMID:
18496394
4.

Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.

Xue S, Katz PO, Banerjee P, Tutuian R, Castell DO.

Aliment Pharmacol Ther. 2001 Sep;15(9):1351-6.

5.

Nocturnal acid breakthrough: pH, drugs and bugs.

Tutuian R, Katz PO, Castell DO.

Eur J Gastroenterol Hepatol. 2004 May;16(5):441-3.

PMID:
15097034
7.

Concomitant Administration of a Histamine2 Receptor Antagonist and Proton Pump Inhibitor Enhances Gastric Acid Suppression.

Abdul-Hussein M, Freeman J, Castell D.

Pharmacotherapy. 2015 Dec;35(12):1124-9. doi: 10.1002/phar.1665. Epub 2015 Dec 1.

PMID:
26621819
8.
9.

Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.

Katz PO, Hatlebakk JG, Castell DO.

Aliment Pharmacol Ther. 2000 Jun;14(6):709-14.

10.

Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.

Peghini PL, Katz PO, Castell DO.

Gastroenterology. 1998 Dec;115(6):1335-9.

PMID:
9834259
11.

Nocturnal gastric acid breakthrough during the administration of rabeprazole and ranitidine in Helicobacter pylori-negative subjects: effects of different regimens.

Adachi K, Komazawa Y, Fujishiro H, Mihara T, Ono M, Yuki M, Kawamura A, Karim Rumi MA, Amano Y, Kinoshita Y.

J Gastroenterol. 2003;38(9):830-5.

PMID:
14564627
12.

[Maintenance therapy of mild form of GERD by H2 receptor antagonists].

Kurosawa S.

Nihon Rinsho. 2000 Sep;58(9):1859-64. Review. Japanese.

PMID:
11004816
13.

Nocturnal acid breakthrough in children with reflux esophagitis taking proton pump inhibitors.

Pfefferkorn MD, Croffie JM, Gupta SK, Molleston JP, Eckert GJ, Corkins MR, Fitzgerald JF.

J Pediatr Gastroenterol Nutr. 2006 Feb;42(2):160-5.

PMID:
16456408
14.

Combination drug therapy for gastroesophageal reflux disease.

Cross LB, Justice LN.

Ann Pharmacother. 2002 May;36(5):912-6. Review.

PMID:
11978171
15.

Persistent acid reflux and symptoms in patients with Barrett's oesophagus on proton-pump inhibitor therapy.

Basu KK, Bale R, West KP, de Caestecker JS.

Eur J Gastroenterol Hepatol. 2002 Nov;14(11):1187-92.

PMID:
12439112
16.

Laryngopharyngeal reflux disease with nocturnal gastric acid breakthrough while on proton pump inhibitor therapy.

Sato K.

Eur Arch Otorhinolaryngol. 2006 Dec;263(12):1121-6. Epub 2006 Jul 15.

PMID:
16845517
17.

Patterns of 24-hour oesophageal acid exposure after acute withdrawal of acid suppression.

Orr WC, Mellow MH, Grossman MR.

Aliment Pharmacol Ther. 1995 Oct;9(5):571-4.

PMID:
8580280
18.

Treatment with proton pump inhibitors induces tolerance to histamine-2 receptor antagonists in Helicobacter pylori-negative patients.

Qvigstad G, Arnestad JS, Brenna E, Waldum HL.

Scand J Gastroenterol. 1998 Dec;33(12):1244-8.

PMID:
9930386
20.

Does long-term medication with a proton pump inhibitor induce a tolerance to H2 receptor antagonist?

Hashimoto H, Kushikata T, Kudo M, Hirota K.

J Gastroenterol. 2007 Apr;42(4):275-8. Epub 2007 Apr 26.

PMID:
17464455

Supplemental Content

Support Center